Last updated on November 2017

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: COPD (Chronic Obstructive Pulmonary Disease)
  • Age: Between 40 - 80 Years
  • Gender: Male or Female
  • Other:
  • Must be 40 years of age and not over 80 year of age to be eligible
  • Must have been a previous or a current smoker with at least a 10-pack year history which means an average of one pack per day for 10 years.
  • You cannot have a diagnosis of Asthma